Also listed on Kotobuki Pharmaceutical Co., Ltd., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends May 29, 2043 · High confidence
20-year base term ends Apr 27, 2042
Held by Tenvie Therapeutics, Inc.
Filed Oct 27, 2023 as application 18/288,588 · Granted Jul 28, 2026
Base term plus 397 days of patent term adjustment (USPTO delay)
Today
2022
2043
Clock starts
Apr 27, 2022
Apr 27, 2022
Term ends
May 29, 2043
May 29, 2043
Granted
Jul 28, 2026
Jul 28, 2026
base term
patent term adjustment
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
397
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 397 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 27, 2022, when application PCT/JP2022/018994, the earliest non-provisional in its chain, was filed (this one was filed Oct 27, 2023) | Apr 27, 2042 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +397 days, USPTO patent term adjustment record | May 29, 2043 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 29, 2043 | High confidence |
Partial family
| Application PCT/JP2022/018994 | PCT application no patent term | no patent term |
| US 12,692,241 | this patent May 2043 | May 2043 |
| Application 19/690,143 | Pending not computed | not computed |
Partial: 1 of the 3 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 27, 2023 Reel 65368, frame 666 | Inagaki, Yusuke; Yamashita, Yumi; Toya, Hiroki; Washio, Takuya; Takahashi, Fumie; Saba, Kengo; Tomiyama, Hiroshi; Iwai, Yoshinori; Nakamura, Akihiko | Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd. | Assignment of Assignor's Interest |
| Oct 27, 2023 reel/frame not recorded | Inagaki, Yusuke; Iwai, Yoshinori; Nakamura, Akihiko; Saba, Kengo; Takahashi, Fumie; Tomiyama, Hiroshi; Toya, Hiroki; Washio, Takuya; Yamashita, Yumi | Astellas Pharma Inc. | Assignment of Assignor's Interest |
| Oct 27, 2023 reel/frame not recorded | Inagaki, Yusuke; Iwai, Yoshinori; Nakamura, Akihiko; Saba, Kengo; Takahashi, Fumie; Tomiyama, Hiroshi; Toya, Hiroki; Washio, Takuya; Yamashita, Yumi | Kotobuki Pharmaceutical Co., Ltd. | Assignment of Assignor's Interest |
| Jan 31, 2024 Reel 66313, frame 287 | Kotobuki Pharmaceutical Co., Ltd. | Astellas Pharma Inc. | Assignment of Assignor's Interest |
| May 16, 2025 Reel 71141, frame 917 | Astellas Pharma Inc. | Nico Therapeutics, Inc. | Assignment of Assignor's Interest |
| Jun 30, 2026 Reel 75861, frame 866 | Nico Therapeutics, Inc. | Tenvie Therapeutics, Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
May 2043
Term ends May 29, 2043. Maintenance fees still fall due before then
Note
The 397 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.